Brief: TELA Bio Announces Pricing Of $13.0 Million Underwritten Registered Direct Offering Of Common Stock And Pre-Funded Warrants
13/11/2025 22:26
Nov 13 (Reuters) - TELA Bio Inc TELA.O: TELA BIO ANNOUNCES PRICING OF $13.0 MILLION UNDERWRITTEN REGISTERED DIRECT OFFERING OF COMMON STOCK AND PRE-FUNDED WARRANTS Source text: ID:nGNX9BMq4r Further company coverage: TELA.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on TELA Bio
See all newsTELA Bio Q1 revenue growth beats estimates, loss widens
Brief: TELA Bio Q1 Revenue USD 19.059 Million Vs. IBES Estimate USD 18.6 Million
Brief: Tela Bio Announces Inducement Grants Under Nasdaq Listing Rule
Medical device maker Becton Dickinson sued over alleged hernia mesh monopoly
Brief: TELA Bio Announces Pricing Of $13.0 Million Underwritten Registered Direct Offering Of Common Stock And Pre-Funded Warrants